How Organ Donation and Transplant Matching Actually Works

Seventeen People Die Every Day Waiting

Every ten minutes, a new name is added to the U.S. organ transplant waiting list. Every day, approximately 17 people on that list die before a compatible organ arrives. As of 2024, more than 103,000 Americans are waiting for a transplant—kidneys make up roughly 83,000 of those cases. The gap between organ supply and demand has persisted for decades despite public awareness campaigns, driver's license registration programs, and policy reforms. Understanding why requires understanding the extraordinary biological and logistical complexity of matching a donor's organ to a recipient who may be a thousand miles away.

The UNOS/OPTN System: Who Manages the List

The United Network for Organ Sharing (UNOS) operates the Organ Procurement and Transplantation Network (OPTN) under a federal contract with the Health Resources and Services Administration. Congress mandated the creation of a national organ sharing network through the National Organ Transplant Act of 1984, making the U.S. the first country to systematically organize organ allocation at a national level.

UNOS maintains the national transplant waiting list, matches donors to recipients, collects transplant outcome data, and sets policy for organ allocation. It operates a 24/7 Organ Center in Richmond, Virginia, staffed by clinical specialists who coordinate matches when organs become available. UNOS also manages the UNET℠ computer system through which transplant centers and organ procurement organizations (OPOs) communicate in real time.

HLA Compatibility: The Biology of Matching

Transplanted organs are foreign tissue. The immune system's job is to destroy foreign tissue. Transplant success depends on minimizing the immunological mismatch between donor and recipient—a compatibility measured through human leukocyte antigen (HLA) typing.

HLA proteins sit on the surface of virtually every nucleated cell in the body and serve as the immune system's identification system—the molecular equivalent of a name tag. T cells scan these markers and attack cells displaying foreign HLA profiles. Organ rejection occurs when recipient immune cells identify the donor organ's HLA pattern as foreign and mount an attack.

• Six HLA antigens are primarily evaluated for transplant matching: HLA-A, HLA-B, HLA-C, HLA-DR, HLA-DQ, and HLA-DP
• Each person inherits one set of HLA antigens from each parent, meaning six potential mismatches per donor-recipient pair
• A zero-antigen-mismatch kidney—perfect HLA compatibility—has the best long-term outcomes and receives priority sharing nationally regardless of geography
• Even poorly matched transplants function with modern immunosuppressive drugs, but well-matched transplants require lower drug doses and have fewer complications

How the Matching Algorithm Works

When a donor organ becomes available, the UNOS computer system generates a ranked list of compatible recipients based on criteria that differ by organ type. The algorithm is not a single universal formula—each organ has its own allocation policy reflecting its scarcity, urgency factors, biological constraints, and historical equity considerations.

For kidneys, the algorithm weighs:

• Blood type compatibility (ABO matching)
• HLA antigen matching (6-antigen match gets highest priority nationally)
• Sensitization status (patients who are highly sensitized—with antibodies to many HLA types from prior transfusions, pregnancies, or transplants—receive priority)
• Time on waiting list (accrued as a tiebreaker)
• Pediatric status (children receive priority from pediatric donors)
• Geographic proximity (reduces cold ischemia time)

For livers, urgency dominates. The Model for End-Stage Liver Disease (MELD) score predicts 90-day mortality from liver failure using serum bilirubin, creatinine, and INR. A patient with a MELD score of 40+ has roughly 70% three-month mortality without transplant. The liver allocation system directs organs to the sickest compatible patients first within geographic zones.

Determining Brain Death: The Prerequisite for Donation

Deceased donor transplants require that the donor meet the legal and medical definition of death. For most solid organ donors, this means brain death—the irreversible cessation of all brain function, including the brain stem that controls breathing and circulation.

Brain death determination follows strict protocols established by the Uniform Determination of Death Act (UDDA), adopted in some form by all 50 states. The evaluation includes:

• Documented cause of brain injury consistent with irreversible damage (stroke, trauma, anoxia)
• Absence of reversible causes (drug intoxication, metabolic derangement, hypothermia)
• Neurological examination showing no response to stimuli and absent brain stem reflexes
• Apnea test: patient does not breathe spontaneously when ventilator is removed temporarily and CO₂ rises above threshold
• Confirmatory tests (EEG, cerebral blood flow studies) where uncertainty exists

Donation after circulatory death (DCD) is a second category where donation occurs after withdrawal of life-sustaining treatment in patients who are not brain dead but have irreversible conditions with no prospect of meaningful recovery. DCD has expanded the donor pool but involves more complex logistics and some organs have reduced viability.

Opt-In vs. Opt-Out: Policy Approaches Worldwide

The United States uses an opt-in system: individuals must affirmatively register as donors. Registration rates vary by state, from about 30% to over 85% of licensed drivers. Opt-in systems typically have lower theoretical donor pools, though family consent remains important regardless of registration in practice.

Spain's consistently high donation rates are often attributed to its transplant coordinator infrastructure—every hospital has a dedicated transplant coordinator, and family conversations happen early in ICU stays—rather than the opt-out policy itself. The U.S.'s relatively high rate reflects decades of public education campaigns and a hospital-based coordinator system, despite maintaining opt-in registration.

Living Donation: Closing the Gap

Approximately 6,500 Americans donate a kidney to a living recipient each year. The kidney is the only organ regularly transplanted from living donors; partial liver lobes and lung lobes are also occasionally donated. Living donor kidneys typically last longer than deceased donor kidneys—median graft survival exceeds 20 years for living donor transplants versus 12–15 years for deceased donor organs—because they have no cold ischemia time.

Paired kidney exchange programs—where incompatible donor-recipient pairs swap in chains involving multiple hospitals—have substantially expanded living donation options. The National Kidney Registry managed over 80-way transplant chains in 2023, matching donors whose intended recipients couldn't receive their organ with other recipients who could.

This article is for informational purposes only. Consult a qualified professional for medical guidance on organ donation and transplantation.